Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

NCT: NCT07599904 · RECRUITING

NCT IDNCT07599904
StatusRECRUITING
Start Date2026-07-13
Completion2031-07
SponsorMedtronic Neurovascular Clinical Affairs (INDUSTRY)
First posted
Last updated

Brief Summary

Post-Market Registry

Frequently Asked Questions

What is REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)?

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry) is a clinical trial registered under NCT07599904. Current status: RECRUITING.

What is the status of NCT07599904?

The current status of NCT07599904 (REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)) is: RECRUITING.

When did REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry) start?

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry) started on 2026-07-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑